Annovis Bio, Inc. (ANVS) Return on equity 2020–2025
Annovis Bio, Inc. (ANVS) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-171.2%FY2025 · since FY2020: -72.4% → -171.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -171.2% | +93.0 pp |
| FY2024 | -264.2% | — |
| FY2022 | -89.4% | -56.9 pp |
| FY2021 | -32.6% | +39.9 pp |
| FY2020 | -72.4% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice